The House Committee on Oversight and Accountability holds a hearing on “Oversight and Reauthorization of the Office of National Drug Control Policy” at 10:00 a.m. ET on July 27.
Dr. Rahul Gupta, director of the office of National Drug Control Policy, will testify.
